Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,629.29
(
0.07%
)
US TECH 100
23,689.20
(
-0.45%
)
Dow Jones
46,216.47
(
-0.02%
)
Brent Oil
101.48
(
-4.79%
)
Bitcoin
70,355.93
(
-1.25%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 165681

Monday, 10/07/2013 1:13:36 PM

Monday, October 07, 2013 1:13:36 PM

Post# of 257259
NVO is investing big money in oral-insulin drugs:

http://in.reuters.com/article/2013/10/07/us-novonordisk-diabetes-pills-idINBRE9960D720131007

Novo Nordisk…aims to develop both an insulin and a so-called GLP-1 agonist in tablet form. The company has around 500 employees working on the development of the tablets… It will spend around 1 billion crowns [~$180M] on the projects this year, with investment increasing towards possible product launches early next decade.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today